Warda Sajjal, Isma Khalid, Amana Fatima, Abeera Merium


1374



ABSTRACT

Background and objectives: Fibroids are the most well-known tumors of the female pelvis. The tumors are considerate and happen in roughly 30% to half of ladies more than 35 years of age, and all the more habitually in individuals of color. The main objective of this study was to analyse the progestin dominant impact consolidatedoral contraception on advancement of uterine fibroids.

Material and methods: This randomized controlled trial was conducted at Women Christian Hospital Multan during from July 2019 to July 2020. The data was collected from 50 patients who were suffering from uterine fibroids and they all treated with combined oral contraception.

Results: The data was collected from 50 patients. 20 patients were considered in control group for comparison with study group. The patients treated with COC didn't have any clinical issues. In 13 patients (13.4%) under monophasic joined pills, the development of fibroids just as issues like menorrhagia, pallor, stomach agony and dysmenorrhea proceeded or expanded. Fundamental issue in 10 patients was serious uterine dying (surmised blood loss of 300ml), 3 experienced stomach and pelvic pain.

Conclusion: It is concluded that uterine fibroids are very common. Numerous ladies need no mediation for their fibroids. Numerous ladies just need traditionalist treatment.



Copyright © Pakistan Journal of Medical & Health Sciences 2024. All rights reserved!